News Snapshot:
Doctor Tatiana Maria Pereira Fernandes receives an injection as she is a volunteer in the Coronavac's trial, SinoVac's coronavirus disease (COVID-19) vaccine at Emilio Ribas Institute, in Sao Paulo, Brazil December 11, 2020. Picture taken Dec. 11, 2020. Amanda Perobelli, Reuters MANILA — The reported 50-percent efficacy of the COVID-19 vaccine from China's Sinovac is "acceptable" as this is the minimum requirement for use, the Department of Science and Technology said on Thursday. A newspaper in Brazil, where late-stage trials of the Sinovac vaccine are running, reported that the drug was over 50% effective. The vaccine is among those the...
